Blog / Archives
Traders and Investors are Winning with Biotech Stocks
Traders and Investors are Outperforming with Biotech Stocks Biotech stocks beat the S&P 500 and technology stocks with the IBB up 29.46%. The XBI is up 37%. The retail investor can achieve good...
Biotech Stocks Cruise to New Highs While Boosting Healthcare Sector…Update-3 DEC 5…alert
Update-3 12/5/25...3:15 PST...EYPT still strong up another 5%;.ADPT down another big 14%-Benziga has a note on a Natera buyout that must be related to drop in ADPT stock. More later but more...
Biotech Deals Propel Sector to New 2025 Highs…Update-4…A bullish signal for upcoming week 11/23.
11/24/25...Update-4---11:00a EST-----GREEN SCREEN DAY in early trading with both IBB and XBI at new 2025 highs, laggard ARKG catching up at $29.34 up over 3%. Many 4% movers from our trading...
Large Cap Biopharmaceuticals Lead the Way for Healthcare Investors…Update-1
Update-1 11/15 Merck buys Cedara for $9.2B for long acting Flu drug. An alternative to vaccines? CDTX up 105% IBB at $164.30 approaching highs of AUG 2021 of $177. Large Cap Biopharma Stocks Lead...
What’s Behind the Moves in the Healthcare Sector: Many Options for investing-Biotech, Medtech, Tools.
An abrupt reversal from "Risk-Off" sentiment launched a rally in some SMID biotechs, precious metals and AI / Semiconductor stocks. The NAZ was up 2.25%. Health Science stocks did well today:...
Healthcare Stocks are Coming Back Fast Boosted by Biotechs…Update-6 COGT !…. And a choppy “risk off market”, a deal on weight -loss drugs.
Update-6 11/10/25...SMID Biotechs in a romp!...Cogent Biosciences (COGT) up 130% on Phase 3 Study. XBI up 1.5% at $110 level. Update-5...11:11a 11/7/25...XBI slices thru support of 20 day down 2.4%...
New M&A Deals Should Propel SMID Biotechs in Q4… Update-1…10/27
Update-1 ...10/27...SMID BIOTECH rally on a green screen day.. many hot biotechs in Russell 2000: AXSM, BBIO,CYTK, CRNX, TEM etc Today we read on Bloomberg at 10a about a deal that said Novartis...
Healthcare Stocks are Coming Back with the XLV up 6.83% MTD, what’s Going on?
HEALTHCARE Stocks Are Coming Back Led by Biopharma so what's next? The XLV portfolio weighting has shifted to LargeCap Biopharma which has performed well (see our articles). Biotech has shown...
Focus on SMID Biotech Stocks to Boost Healthcare Portfolio Performance…Update-4…profit taking day
Update-4 10/22/25,,,Small cap biotech momentum rally fizzles on profit taking. Healthcare investors should look at Medtech and US Medical Devices with the IHI and health sciences sector with FSMEX....
Biotech Update Near 2025 Highs…Update-3 SMID biotech stocks look good
Update-3 10/14...A volatile mixed day with a slight shift away from large cap tech to speculative small caps favoring biotechs. Regional banks strong. Rare earth conflicts with China .Looking at our...